Kaplan Brett 4
4 · Compass Therapeutics, Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Kaplan Brett
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-18+30,000→ 30,000 totalExercise: $2.40Exp: 2032-02-17→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option vests in substantially equal monthly installments over four years.